FDA Approves Baxter Theranova
Baxter’s new Theranova dialyzer is designed to filter out a wider range of solutes from the blood to more closely mimic healthy kidneys—including molecules linked with heart and inflammatory disease seen in kidney failure
Read the full article » | Posted 09-11-2020
Related Articles
- CMS Relocates ESRD Survey Procedures and Interpretive Guidance Posted 06-17-2026
- CMS announced new 5-year contracts for ESRD Networks, which started May 1 Posted 06-17-2026
- Simon Davies Discusses the Role of PD in Expanding Dialysis Acess Posted 05-15-2026
- Less Home Dialysis and Transplant in Pediatric Patients Transitioning to Adult Clinics Posted 05-15-2026

